PPARG and osteoporosis: Accumulating experimental evidence indicates that asiatic acid influences bone remodeling by attenuating osteoclast activity and modulating inflammatory and metabolic signaling, particularly through NF-κB- and PPARγ-associated mechanisms, leading to reduced bone loss in experimental osteoporosis models [18,28,29].